AN2 Therapeutics, Inc. (ANTX)
3.55
-0.09
(-2.47%)
USD |
NASDAQ |
Oct 23, 16:00
3.555
0.00 (0.00%)
After-Hours: 20:00
AN2 Therapeutics Market Cap : 128.90M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 128.90M |
| October 22, 2026 | 132.16M |
| October 21, 2026 | 130.71M |
| October 20, 2026 | 129.26M |
| October 19, 2026 | 122.36M |
| October 16, 2026 | 122.72M |
| October 15, 2026 | 130.71M |
| October 14, 2026 | 128.53M |
| October 13, 2026 | 130.71M |
| October 12, 2026 | 156.13M |
| October 09, 2026 | 159.76M |
| October 08, 2026 | 169.92M |
| October 07, 2026 | 176.10M |
| October 06, 2026 | 184.09M |
| October 05, 2026 | 203.69M |
| October 02, 2026 | 207.32M |
| October 01, 2026 | 204.05M |
| September 30, 2026 | 193.16M |
| September 29, 2026 | 184.81M |
| September 28, 2026 | 181.91M |
| September 25, 2026 | 177.19M |
| September 24, 2026 | 177.55M |
| September 23, 2026 | 175.37M |
| September 22, 2026 | 175.37M |
| September 21, 2026 | 180.09M |
| Date | Value |
|---|---|
| September 18, 2026 | 183.36M |
| September 17, 2026 | 177.91M |
| September 16, 2026 | 193.89M |
| September 15, 2026 | 194.61M |
| September 14, 2026 | 198.25M |
| September 11, 2026 | 196.43M |
| September 10, 2026 | 206.60M |
| September 09, 2026 | 208.05M |
| September 08, 2026 | 217.13M |
| September 04, 2026 | 213.86M |
| September 03, 2026 | 216.04M |
| September 02, 2026 | 216.04M |
| September 01, 2026 | 198.97M |
| August 31, 2026 | 201.51M |
| August 28, 2026 | 202.60M |
| August 27, 2026 | 208.41M |
| August 26, 2026 | 200.79M |
| August 25, 2026 | 205.51M |
| August 24, 2026 | 204.42M |
| August 21, 2026 | 210.95M |
| August 20, 2026 | 210.23M |
| August 19, 2026 | 216.40M |
| August 18, 2026 | 216.76M |
| August 17, 2026 | 208.05M |
| August 14, 2026 | 217.49M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cocrystal Pharma, Inc. | 13.10M |
| CNBX Pharmaceuticals, Inc. | 0.1476M |
| Arvinas, Inc. | 476.69M |
| Fulcrum Therapeutics, Inc. | 280.73M |
| Definium Therapeutics, Inc. | 4.793B |
Market Cap Related Metrics
| Price to Book Value | 1.698 |
| Price | 3.55 |
| Earnings Yield | -30.23% |